No connection

Search Results

ASBA

BEARISH
$25.11 Live
None · NYSE
$22.99 52W Range $25.3
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
65%
The Advanced Deterministic Scorecard reveals severe financial health concerns, highlighted by a critically low Piotroski F-Score of 1/9, indicating weak profitability, poor leverage control, and deteriorating operating efficiency. The absence of an Altman Z-Score prevents definitive bankruptcy risk assessment, but the lack of financial data across valuation, profitability, and leverage metrics suggests systemic reporting or structural issues. Despite modest positive price momentum over 1Y and 5Y periods, the technical trend is rated extremely bearish at 10/100, reflecting weak market conviction. With no verifiable fundamentals to support valuation and zero dividend strength, the investment case lacks a factual foundation.

Key Strengths

Modest long-term price appreciation: +22.4% over 3Y and 5Y periods suggests some investor retention or macro support.
Current price near 52-week high: Trading at $25.11 vs. 52-week high of $25.30 indicates recent price resilience.
Low short-term volatility: Minimal movement in 1M (+0.7%) and 1W (+0.8%) suggests stability, albeit in a tight range.
Insider sentiment not deeply negative: Score of 40/100 implies no aggressive insider selling, though not supportive.
No reported debt burden: Total Debt listed as $N/AB may indicate minimal or no debt, though unconfirmed.

Key Risks

Critically low Piotroski F-Score of 1/9: Signals severe financial distress, with likely negative earnings, declining margins, and poor operational performance.
Incomplete financial data: Absence of P/E, P/B, margins, ROE, ROA, and cash flow metrics prevents reliable analysis and suggests potential disclosure issues.
No calculable Altman Z-Score: Inability to assess bankruptcy risk due to missing financial inputs is a major red flag.
Extremely weak technical trend: Technical Trend score of 10/100 indicates strong bearish momentum or lack of buyer interest.
Zero dividend strength: Dividend Strength of 0/100 confirms no income appeal or capital return policy.

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
20
Weak
Value
20
Future
30
Past
40
Health
10
Dividend
0
AI Verdict
Highly unfavorable investment profile due to lack of transparency and weak financial health indicators.
Key drivers: Piotroski F-Score of 1/9, Missing Altman Z-Score and valuation metrics, Technical Trend at 10/100, No dividend strength
Confidence
60%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • All valuation ratios (P/E, P/B, P/S, EV/EBITDA) are N/A
  • Graham Number and Intrinsic Value unavailable
Future
30/100

Ref Growth rates

Positives
  • 5Y and 3Y price changes at +22.4% suggest potential growth expectations
Watchpoints
  • Revenue and earnings growth data unavailable (YoY and Q/Q)
  • No Forward P/E or PEG to assess future earnings expectations
Past
40/100

Ref Historical trends

Positives
  • 1Y price change of +8.3% and 6M of +5.9% show positive historical performance
Watchpoints
  • No historical financial data (margins, ROE, cash flow) to validate performance
Health
10/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 1/9 indicates critical financial weakness
  • Altman Z-Score unavailable, preventing distress risk assessment
  • Debt/Equity, Current Ratio, and Quick Ratio all missing
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength 0/100
  • All dividend metrics (Yield, Rate, Payout) are N/A

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.11

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ASBA and closest competitors.

Updated 2026-01-23
ASB
ASBA
Primary
5Y
+22.4%
3Y
+22.4%
1Y
+8.3%
6M
+5.9%
1M
+0.7%
1W
+0.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Past News Coverage

Recent headlines mentioning ASBA from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile